Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Watering Collecting Duct Cysts: Are Aquaporin2+ Progenitors the Answer?Journal of the American Society of Nephrology, 2024-04, Vol.35 (4), p.387-388 [Peer Reviewed Journal]EISSN: 1533-3450 ;DOI: 10.1681/ASN.0000000000000333 ;PMID: 38557785Full text available |
|
2 |
Material Type: Article
|
In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney diseaseSLAS technology, 2023-08, Vol.28 (4), p.223-229 [Peer Reviewed Journal]2023 The Author(s) ;Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. ;ISSN: 2472-6303 ;EISSN: 2472-6311 ;DOI: 10.1016/j.slast.2023.02.001 ;PMID: 36804177Full text available |
|
3 |
Material Type: Article
|
Inhibition of asparagine synthetase effectively retards polycystic kidney disease progressionEMBO molecular medicine, 2024-04 [Peer Reviewed Journal]2024. The Author(s). ;EISSN: 1757-4684 ;DOI: 10.1038/s44321-024-00071-9 ;PMID: 38684863Full text available |
|
4 |
Material Type: Article
|
Aortic Dissection in Familial Patients with Autosomal Dominant Polycystic Kidney DiseaseAnnals of Vascular Diseases, 2021, pp.cr.20-00149 [Peer Reviewed Journal]2021 The Editorial Committee of Annals of Vascular Diseases. This article is distributed under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided the credit of the original work, a link to the license, and indication of any change are properly given, and the original work is not used for commercial purposes. Remixed or transformed contributions must be distributed under the same license as the original. ;ISSN: 1881-641X ;EISSN: 1881-6428 ;DOI: 10.3400/avd.cr.20-00149Full text available |
|
5 |
Material Type: Article
|
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney diseaseKidney international, 2019-07, Vol.96 (1), p.159-169 [Peer Reviewed Journal]2019 International Society of Nephrology ;Copyright © 2019 International Society of Nephrology. All rights reserved. ;ISSN: 0085-2538 ;EISSN: 1523-1755 ;DOI: 10.1016/j.kint.2018.11.044 ;PMID: 30898339Full text available |
|
6 |
Material Type: Article
|
Rene, ADPKD e COVID-19: il doppio ruolo della fragilità renaleGiornale di clinica nefrologica e dialisi, 2020-07, Vol.32 (1), p.99-101 [Peer Reviewed Journal]ISSN: 2705-0076 ;EISSN: 2705-0076 ;DOI: 10.33393/gcnd.2020.2165Full text available |
|
7 |
Material Type: Article
|
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney international, 2015-07, Vol.88 (1), p.17-27 [Peer Reviewed Journal]2015 International Society of Nephrology ;Copyright Nature Publishing Group Jul 2015 ;ISSN: 0085-2538 ;EISSN: 1523-1755 ;DOI: 10.1038/ki.2015.59 ;PMID: 25786098Full text available |
|
8 |
Material Type: Article
|
European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participantsNephrology, dialysis, transplantation, 2018-04, Vol.33 (4), p.563-573 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. 2017 ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfx327 ;PMID: 29309655Full text available |
|
9 |
Material Type: Article
|
Detection and characterization of mosaicism in autosomal dominant polycystic kidney diseaseKidney international, 2020-02, Vol.97 (2), p.370-382 [Peer Reviewed Journal]2019 International Society of Nephrology ;Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0085-2538 ;EISSN: 1523-1755 ;DOI: 10.1016/j.kint.2019.08.038 ;PMID: 31874800Full text available |
|
10 |
Material Type: Article
|
Rapidly progressive nephromegaly in a neonate with autosomal recessive poly cystic kidney diseaseJournal of nephropathology, 2017-10, Vol.6 (4), p.363-367 [Peer Reviewed Journal]ISSN: 2251-8363 ;EISSN: 2251-8819 ;DOI: 10.15171/jnp.2017.60Full text available |
|
11 |
Material Type: Article
|
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease Internationalinfo:eu-repo/semantics/OpenAccess ;ISSN: 0931-0509 ;EISSN: 1460-2385Full text available |
|
12 |
Material Type: Article
|
The association of urinary epidermal growth factors with ADPKD disease severity and progressionNephrology, dialysis, transplantation, 2023-09, Vol.38 (10), p.2266-2275 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. 2023 ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfad050Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney DiseaseAmerican journal of human genetics, 2018-05, Vol.102 (5), p.832-844 [Peer Reviewed Journal]2018 American Society of Human Genetics ;Copyright © 2018 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved. ;Distributed under a Creative Commons Attribution 4.0 International License ;2018 American Society of Human Genetics. 2018 American Society of Human Genetics ;ISSN: 0002-9297 ;ISSN: 1537-6605 ;EISSN: 1537-6605 ;DOI: 10.1016/j.ajhg.2018.03.013 ;PMID: 29706351Full text available |
|
14 |
Material Type: Article
|
Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility FactorsToxicological sciences, 2017-01, Vol.155 (1), p.61-74 [Peer Reviewed Journal]The Author 2016. Published by Oxford University Press on behalf of the Society of Toxicology. ;The Author 2016. Published by Oxford University Press on behalf of the Society of Toxicology. 2016 ;ISSN: 1096-6080 ;EISSN: 1096-0929 ;DOI: 10.1093/toxsci/kfw193 ;PMID: 27655350Full text available |
|
15 |
Material Type: Article
|
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeNephrology, dialysis, transplantation, 2016-03, Vol.31 (3), p.337-348 [Peer Reviewed Journal]The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author 2016. Published by Oxford University Press on behalf of ERA-EDTA. 2016 ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfv456 ;PMID: 26908832Full text available |
|
16 |
Material Type: Article
|
Autopsy of a 45-year-old Man with Liver Failure Due to Polycystic Liver DiseaseInternal Medicine, 2024, pp.2485-23 [Peer Reviewed Journal]2024 by The Japanese Society of Internal Medicine ;ISSN: 0918-2918 ;EISSN: 1349-7235 ;DOI: 10.2169/internalmedicine.2485-23 ;PMID: 38296484Full text available |
|
17 |
Material Type: Article
|
The Structure of the Polycystic Kidney Disease Channel PKD2 in Lipid NanodiscsCell, 2016-10, Vol.167 (3), p.763-773.e11 [Peer Reviewed Journal]2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2016.09.048 ;PMID: 27768895Full text available |
|
18 |
Material Type: Article
|
AN EXPERIENCE OF SUPINE PCNL ON BILATERAL STAGHORN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASEJurnal urologi Indonesia = Indonesian journal of Urology, 2020-07, Vol.27 (2), p.215-218 [Peer Reviewed Journal]ISSN: 0853-442X ;EISSN: 2355-1402 ;DOI: 10.32421/juri.v27i2.562Full text available |
|
19 |
Material Type: Article
|
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease InternationalNephrology, dialysis, transplantation, 2022-04, Vol.37 (5), p.825-839 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfab312 ;PMID: 35134221Full text available |
|
20 |
Material Type: Article
|
Autosomal Dominant Polycystic Kidney Disease in which the Polycystic Liver Volume was Reduced by Rigorous Blood Pressure ControlInternal Medicine, 2021, pp.7441-21 [Peer Reviewed Journal]2021 by The Japanese Society of Internal Medicine ;ISSN: 0918-2918 ;EISSN: 1349-7235 ;DOI: 10.2169/internalmedicine.7441-21Full text available |